This is a $299,999 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Ocean Nano TECH LLC, a woman-owned small disadvantaged business based in San Diego, California. The contract is for the development of a Quantum Dot Förster Resonance Energy Transfer (FRET) Immunoassay to quantify intramolecular epitopes of analytes in tissue sections, as part of the Small Business Innovation Research (SBIR) program....
This federal contract award was made by the National Cancer Institute to Ocean Nano TECH LLC, a woman-owned small business, to conduct research and development on multi-biomarker imaging using quantum dots for the prediction of HPV-associated cancers. The $1,000,000.00 cost-plus-fixed-fee contract does not have a set-aside designation. Ocean Nano TECH LLC has also received federal grant awards from the National Institutes of Health National Institute of Environmental Health Sciences for $185,847...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small business. The contract, valued at $150,000.00, is for research and development related to the "TAS::75 0849::TAS" requirement. Ocean Nano TECH LLC is a provider of nanotechnology products and services, including for environmental testing and targeted...
This is a $1,200,000.00 cost-plus-fixed-fee contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Ocean Nano TECH LLC, a woman-owned small business. The contract is for the development of "target specific and drug loaded iron oxide nanoparticles for cancer imaging and therapy." This is a small business set-aside contract with a completion date of March 31, 2015. Ocean Nano TECH LLC is a provider of...
The Department of Health and Human Services awarded a $199,993 Small Business Innovation Research (SBIR) Phase I contract to Ocean Nano TECH LLC, a woman-owned small disadvantaged business, for the development of "Target Specific and Drug Loaded Iron Oxide Nanoparticles for Cancer Imaging and Therapy." The contract, with a completion date of March 30, 2010, is a firm-fixed-price definitive contract. Ocean Nano TECH LLC has also received several federal grant awards and sub-awards to...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The $149,991 Firm Fixed Price contract supports research and development of biomedical nanotechnology products and services. The contract has a Total Small Business set-aside. According to the information provided, Ocean Nano TECH LLC has also received prior federal grant awards and sub-awards...
This is a $1,725,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The contract is for the development of targeted molecular imaging agents to detect high-risk atherosclerotic plaque, in combination with existing imaging modalities. Ocean Nano TECH LLC is a nanotechnology...
The U.S. government awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Evident Technologies, Inc., a small business located in Troy, NY. The $172,216.00 fixed-price contract is for the development of quantum dot nanotechnology to quantify marker expression in breast cancer. The contract was awarded on August 2, 2006 by a U.S. government agency, with a completion date of August 1, 2007. This SBIR Phase I contract is part of the agency's initiatives to support...
This SBIR Phase II contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The $997,267 cost-plus-fixed-fee contract is for the development of "bright, photostable surface enhanced fluorescent nanotags" to advance biomedical technologies. Nanocomposix has previously provided products and R&D services to NCI, FDA, CDC, and the...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...